UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial

Breast cancer research and treatment, 2009-10, Vol.117 (3), p.561-567

2009

Volltextzugriff (PDF)

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4071-4082

2022

Volltextzugriff (PDF)

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study

British journal of cancer, 2013-03, Vol.108 (5), p.1195-1208

2013

Volltextzugriff (PDF)

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

British journal of cancer, 2011-05, Vol.104 (11), p.1762-1769

2011

Volltextzugriff (PDF)

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer

Breast cancer research and treatment, 2016-11, Vol.160 (2), p.313-322

2016

Volltextzugriff (PDF)

Factors influencing return to work: a narrative study of women treated for breast cancer

European journal of cancer care, 2010-05, Vol.19 (3), p.317-323

2010

Volltextzugriff (PDF)

Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer

Oncogene, 2007-10, Vol.26 (49), p.6997-7005

2007

Volltextzugriff (PDF)

Bone Mineral Density Among Premenopausal Women With Early Breast Cancer in a Randomized Trial of Adjuvant Endocrine Therapy

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3694-3699

2004

Volltextzugriff (PDF)

Increased long-term risk of fatal breast cancer in patients with high intra-tumor heterogeneity of the estrogen receptor – Retrospective analyses of the STO-3 trial

ANNALS OF ONCOLOGY, 2017, Vol.28, p.i10

2017

Volltextzugriff (PDF)

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer

JNCI : Journal of the National Cancer Institute, 2009-03, Vol.101 (5), p.341-349

2009

Volltextzugriff (PDF)

Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study

European journal of cancer (1990), 2006-05, Vol.42 (7), p.895-904

2006

Volltextzugriff (PDF)

Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer

Annals of oncology, 2013-08, Vol.24 (8), p.1994-1999

2013

Volltextzugriff (PDF)

The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer

Journal of cancer research and clinical oncology, 2015-05, Vol.141 (5), p.797-804

2015

Volltextzugriff (PDF)

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

The journal of pathology. Clinical research, 2017-01, Vol.3 (1), p.38-43

2017

Volltextzugriff (PDF)

Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies

JNCI : Journal of the National Cancer Institute, 1995-05, Vol.87 (9), p.645-651

1995

Volltextzugriff (PDF)

1812 Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival. Retrospective analyses of the STO3 randomizedtrial

European journal of cancer (1990), 2015-09, Vol.51, p.S269-S269

2015

Volltextzugriff (PDF)

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

British journal of cancer, 2007-03, Vol.96 (5), p.801-807

2007

Volltextzugriff (PDF)

Impact of tumour size on axillary involvement and distant dissemination in breast cancer

British journal of cancer, 2009-09, Vol.101 (6), p.902-907

2009

Volltextzugriff (PDF)

Thymidine Kinase 1 is a Potential Marker for Prognosis and Monitoring the Response to Treatment of Patients with Breast, Lung, and Esophageal Cancer and Non-Hodgkin's Lymphoma

Nucleosides, nucleotides & nucleic acids, 2010-06, Vol.29 (4-6), p.352-358

2010

Volltextzugriff (PDF)

Metachronous contralateral breast cancer: An analysis of risk factors and prognosis in 42,670 women in Sweden

JOURNAL OF CLINICAL ONCOLOGY, 2011, Vol.29 (15_suppl), p.1568-1568

2011

Volltextzugriff (PDF)

Age-specific trends of survival in metastatic breast cancer: Data from a population-based cancer registry in Stockholm, Sweden

JOURNAL OF CLINICAL ONCOLOGY, 2010, Vol.28 (15_suppl), p.1058-1058

2010

Volltextzugriff (PDF)

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial

British journal of cancer, 2011-03, Vol.104 (6), p.899-902

2011

Volltextzugriff (PDF)

Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1348-1353

1997

Volltextzugriff (PDF)

300P Gene expression landscape of the long-term tamoxifen resistance in premenopausal ER+ breast cancer patients in the STO-5 controlled randomized clinical trial with >20-year follow-up

Annals of oncology, 2024-09, Vol.35, p.S340-S340

2024

Volltextzugriff (PDF)

409P Biological tumor traits predicting late recurrence in premenopausal breast cancer patients: Insights from the STO-5 trial with 20-year follow-up

Annals of oncology, 2024-09, Vol.35, p.S390-S390

2024

Volltextzugriff (PDF)

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(369)
Mit Volltextzugriff
(349)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer

Factors influencing return to work: a narrative study of women treated for breast cancer

Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer

Bone Mineral Density Among Premenopausal Women With Early Breast Cancer in a Randomized Trial of Adjuvant Endocrine Therapy

Increased long-term risk of fatal breast cancer in patients with high intra-tumor heterogeneity of the estrogen receptor – Retrospective analyses of the STO-3 trial

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer

Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study

Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer

The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies

1812 Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival. Retrospective analyses of the STO3 randomizedtrial

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

Impact of tumour size on axillary involvement and distant dissemination in breast cancer

Thymidine Kinase 1 is a Potential Marker for Prognosis and Monitoring the Response to Treatment of Patients with Breast, Lung, and Esophageal Cancer and Non-Hodgkin's Lymphoma

Metachronous contralateral breast cancer: An analysis of risk factors and prognosis in 42,670 women in Sweden

Age-specific trends of survival in metastatic breast cancer: Data from a population-based cancer registry in Stockholm, Sweden

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial

Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy

300P Gene expression landscape of the long-term tamoxifen resistance in premenopausal ER+ breast cancer patients in the STO-5 controlled randomized clinical trial with >20-year follow-up

409P Biological tumor traits predicting late recurrence in premenopausal breast cancer patients: Insights from the STO-5 trial with 20-year follow-up

Suchergebnisse filtern